AIM
AIM
AMEX · Biotechnology

Aim Immunotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.34
-0.22 (-39.66%)
As of May 10, 11:02 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +6,440.4% upside
Low Target $15.13
Average Target $22.10
High Target $31.02
Current Price $0.34
Current
$0.34
Target
$22.10
$15.13 $22.10 avg $31.02
Scenario Analysis
Bear Case
$15.13
4,377.7%
Low target
Base Case
$22.10
+6,440.4%
Avg target
Bull Case
$31.02
+9,080.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$19.74
-98.3% from high
52-Week Low
$0.46
+-26.7% from low
Target vs 52W High
$22.10
+12.0% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.37
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%